An2 Therapeutics, Inc.
ANTX
Revenue
0.00
0.000.00%
-Assets
108.48M
▼-12.78M▼-10.54%
3 Months ChangeLiabilities
10.13M
▼-536.00k▼-5.03%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-19
Form 8-K
ID: 0001193125-24-202430
2024-08-13
Form 10-Q
ID: 0000950170-24-096243
2024-08-13
Form 8-K
ID: 0000950170-24-096173
2024-08-08
Form 8-K
ID: 0001193125-24-197047
2024-06-24
Form 8-K
ID: 0001193125-24-166938
2024-05-14
Form 10-Q
ID: 0000950170-24-059556
2024-05-14
Form 8-K
ID: 0000950170-24-059527
2024-03-28
Form 8-K
ID: 0000950170-24-038055
2024-02-12
Form 8-K
ID: 0001193125-24-031008
2023-11-09
Form 10-Q
ID: 0000950170-23-062081